SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
17
Frequently Asked Questions
What is Market Cap of SeaStar Medical Holding Corp?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. SeaStar Medical Holding Corp market cap is $88.23M.
What is the 52-week high for SeaStar Medical Holding Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SeaStar Medical Holding Corp 52 week high is $12.50 as of August 30, 2026.
What is the 52-week low for SeaStar Medical Holding Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SeaStar Medical Holding Corp 52 week low is $2.07 as of August 30, 2026.
What is SeaStar Medical Holding Corp stock price today?
SeaStar Medical Holding Corp stock price today is $3.09.
What was SeaStar Medical Holding Corp stock price yesterday?
SeaStar Medical Holding Corp stock price yesterday was $3.10.
What is the PE ratio of SeaStar Medical Holding Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. SeaStar Medical Holding Corp's P/E ratio is -0.79.
What is the Price-to-Book ratio of SeaStar Medical Holding Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. SeaStar Medical Holding Corp P/B ratio is 3.064.
What is the 50-day moving average of SeaStar Medical Holding Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. SeaStar Medical Holding Corp 50-day moving average is $3.68.
How many employees does SeaStar Medical Holding Corp have?